A91 Partners is an India-focused venture capital firm that primarily invests patient capital in established, private, small to mid-sized companies at the early growth or late venture capital stage. Their investment strategy targets sectors such as consumer goods and services, healthcare, financial services, and technology.
They made 1 investments in the last 12 months. Their most common stage is series-b (40% of deals). Average disclosed round size is $53.1M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$1.5B
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 MoEngage | Series F | $100M | Nov 2025 |
 SUGAR Cosmetics | Series D | $50M | May 2022 |
 VideoVerse | Series B | $46.8M | Apr 2022 |
| PPublic App | Series B | $41M | Mar 2021 |
| AAye Finance | Series E | $27.5M | Jun 2020 |
Top Co-Investors
Falcon Edge1 shared
L Catterton1 shared
India Quotient1 shared
Goldman Sachs Alternatives1 shared
Alpha Wave Global1 shared
Innoven Capital1 shared
Pacific Western Bank1 shared
Last updated: 8 March 2026